Perioperative fl uid management remains controversial. Nevertheless, its optimization is essential to reducing the risk of postoperative complications, which have been shown to profoundly affect patients' short-and long-term outcomes. Current evidence favors a "fl ow-guided" approach to perioperative fl uid administration, which uses variables such as stroke volume and cardiac output as the basis for guiding fl uid requirements. The optimal fl uid is controversial, although colloids appear to have some physiologic advantages over crystalloids. Minimally invasive technologies have emerged for intraoperative monitoring of blood fl ow, which may enable more precise fl uid titration.
Intraoperative esophageal Doppler monitoring is a simple technique for titrating boluses of fl uid based on continuous estimations of stroke volume.
Administration of suffi cient fl uids early in the course of surgery may be more important than the total volume of fl uid administered in improving patient outcomes.
Intraoperative fl uid needs are highly variable, underscoring the need for individual monitoring and assessment. P erioperative fl uid management remains controversial. Until recently, fl uid management was guided by targets such as urine output, static pressures, blood pressure, and other physiologic variables. Such physiologic signs, however, are inadequate for detecting subclinical hypovolemia. This has prompted the emergence of an approach to fl uid administration based on stroke volume and cardiac output-a "fl ow-guided" approach-designed to overcome the inadequacies of conventional physiologic signs and improve outcomes. Recent technological advances are permitting noninvasive guidance of intravenous fl uid therapy to optimize intravascular volume status.
This article reviews the rationale for perioperative fl uid management, strategies for perioperative fl uid therapy and their associated outcomes, the types of volume expanders used, and considerations for improving perioperative fl uid administration.
  WHY FLUID MANAGEMENT MATTERS

Postoperative complications predict survival
In 2005, Khuri et al published a study of survival after major surgery that starkly illustrated the prognostic importance of postoperative complications. 1 In an effort to identify predictors of long-term survival, they analyzed a National Surgical Quality Improvement Program database of 105,951 patients who underwent eight common operations at Veterans Administration facilities. They found that the most important determinant of reduced postoperative survival over 8 years of follow-up was the occurrence of a complication within 30 days after surgery. The presence of a postoperative complication was a stronger predictor of death than any intraoperative or preoperative risk factor.
Fluid management is key to preventing complications
Optimizing perioperative fl uid management is essential to reducing the risk of postoperative complications and mortality. Surgical patients are more likely to have serious complications and die if they have limited physiologic reserve. Adequate fl uid administration may reduce the stress response to surgical trauma and support recovery.
Building on early work showing that survivors of major surgery have consistently higher postoperative cardiac output and oxygen delivery (DO 2 ) than do nonsurvivors, 2,3 a seminal study by Shoemaker et al showed that these types of blood fl ow-related parameters are predictive of both survival and complication-free survival. 4 Specifi cally, Shoemaker and his team showed that a protocol designed to achieve DO 2 of at least 600 mL/min/m 2 was associated with reductions in both postoperative complications and death. 4    PROBLEMS WITH PERIOPERATIVE FLUID THERAPY-AND EFFORTS TO OVERCOME THEM Despite the utility of fl uid management in reducing postoperative complications, perioperative fl uid therapy is fraught with several fundamental problems:
• Blood volume cannot be evaluated accurately.
• Fluid overload cannot be identifi ed accurately, apart from tissue edema as a result of gross fl uid overload.
• Hypovolemia cannot be identifi ed accurately. Commonly measured variables (heart rate, blood pressure, base excess, lactate) are late markers, and the patient's status upon admission to the operating room is often unknown.
• Tissue perfusion cannot be evaluated accurately. Although lactate and venous oxygen saturation are surrogate markers, genuinely accurate markers for tissue perfusion are lacking.
For these reasons, fl uids are commonly administered without the guidance of direct markers of fl uid status.
Assessing fl ow-guided fl uid therapy
These shortcomings prompted me and several other researchers to assess the evidence regarding a fl ow-guided approach to fl uid administration, which aims to achieve maximal cardiac output and stroke volume while avoiding excess fl uid administration. We conducted a systematic literature search for randomized controlled trials evaluating the postsurgical effects of perioperative fl uid therapy to increase global blood fl ow to explicitly defi ned goals, after which we performed a meta-analysis of the 22 qualifying studies. 5 The trials collectively included 4,546 patients undergoing relatively high-risk elective or emergency surgery, consisting of general, vascular, cardiac, orthopedic, and urologic procedures. Overall mortality in these trials was 10.6% (481 deaths). The primary outcome assessed was mortality; secondary outcomes included morbidity and length of stay in the hospital and in the intensive care unit. Outcomes were assessed according to the timing of the intervention, the fl uid type, and explicit measured goals. Fluids were given to all patients, usually as a dynamic bolus, using a fl ow-guided approach above and beyond that of the control group.
Our analysis found that a fl ow-guided protocol was associated with a signifi cant reduction in mortality compared with control protocols (odds ratio = 0.82 [95% CI, 0.67-0.99]; P = .04). 5 However, sensitivity analysis showed that the largest and best-designed studies tended to yield no signifi cant differences in mortality between the groups, which highlights the remaining need for larger studies to more defi nitively clarify the effect on mortality.
Timing of administration (ie, whether fl uid was given pre-, intra-, or postoperatively) infl uenced the primary outcome: compared with control, fl ow-guided fl uid therapy was associated with a signifi cant reduction in mortality only when administered intraoperatively, but not when given preoperatively or postoperatively. 5 Length of hospital stay was reduced by approximately 1.6 days with fl ow-guided therapy compared with control (P < .00001), but there was no signifi cant difference between approaches in terms of intensive care unit stay. 5 Postoperative complication rates are diffi cult to compare, given the lack of a uniform defi nition of a complication and the relative importance of different complications. Nevertheless, when grouped as a whole, the rate of complications was 48% lower (P < .00001) with fl owguided therapy compared with control. Of all outcomes assessed, the effect on complications was the most consistent among all the studies in the analysis. To provide an example using one easily defi ned complication, the incidence of renal failure was reduced by 35% with fl owguided therapy compared with control (P = .002). 5 
  COLLOID OR CRYSTALLOID?
Two pharmacologically distinct classes Intravenous fl uids can be broadly classifi ed into colloid and crystalloid solutions, and the relative merits of these two fl uid classes are at the center of an enduring debate that predates the advent of fl ow-based fl uid administration. Despite fundamental differences in their pharmacokinetics and other characteristics, colloids and crystalloids are often not suffi ciently distinguished from one another in discussions of perioperative fl uid therapy.
The effect of a colloid depends on its molecular weight. Ninety minutes following administration, a signifi cant proportion of a colloid with a high molecular weight (eg, hydroxyethyl starch) will be retained in the circulation. In contrast, crystalloid solutions (eg, 0.9% saline) readily disappear from the circulation, owing to the ease with which they travel across the cell membrane. No evidence of outcome differences A systematic literature review by Choi et al refl ects the current state of knowledge on the relative effects of colloids and crystalloids for fl uid resuscitation. 7 It concluded that there are no apparent differences between these fl uid classes in their effects on pulmonary edema, mortality, or length of stay. The authors noted that methodologic limitations of the available comparative studies prevent meaningful conclusions and that larger randomized controlled trials are needed to detect any differences in outcomes between the two classes.
FLUID MANAGEMENT
Although using a crystalloid for fl uid resuscitation probably results in a greater volume of fl uid given, a study known as SAFE (Saline versus Albumin Fluid Evaluation), 8 published after the Choi analysis, showed no differences in 28-day all-cause mortality or other signifi cant outcomes between patients randomized to the colloid (4% albumin) and those assigned to the crystalloid (0.9% saline). Patients receiving the colloid had a higher central venous pressure at all time points, a lower heart rate at the end of the fi rst day, and less overall volume on days 1 and 2 compared with patients receiving the crystalloid. While SAFE was conducted in critically ill patients, these physiologic advantages of the colloid may have implications for results in the perioperative arena, although this remains speculative.
   INTRAOPERATIVE MONITORING
TO OPTIMIZE FLUID THERAPY Another important issue is the emergence of minimally invasive technologies for monitoring hemodynamic measures intraoperatively. The aim is to enable more precise tailoring of fl uid therapy to meet patient needs on a case-by-case basis.
One of the simplest of these techniques is esophageal Doppler monitoring to measure descending aortic blood fl ow using Doppler ultrasonography. The technique is used to titrate repeated boluses of fl uid based on continuous estimations of stroke volume and surrogate markers of preload indices. Typical protocols for esophageal Doppler monitoring call for administration of colloid to maintain a descending thoracic corrected fl ow time of no more than 0.35 seconds and stroke volume increments of 10%.
Phan et al recently published a meta-analysis to assess the effect of intraoperative esophageal Doppler monitoring in guiding fl uid therapy to optimize intravascular volume status. 9 The analysis, which included nine randomized controlled trials in a total of 920 patients, found statistically signifi cant reductions in the rate of complications and in length of hospital stay with the use of esophageal Doppler monitoring; there was no difference in mortality. Use of Doppler monitoring was associated with an increase (+671 mL) in the volume of colloid administered and a decrease (-156 mL) in the volume of crystalloid.
Timing of fl uid administration can be critical
One of the trials in the above meta-analysis illustrated that the timing of fl uid administration might be more critical than the volume of fl uid given. Noblett et al placed an esophageal Doppler probe in each of a series of 108 patients undergoing colorectal resection; 10 the control group received perioperative fl uid at the anesthesiologist's discretion, whereas the intervention group received additional colloid boluses based on Doppler assessment. While the overall volume of colloid given was comparable between the two groups, the intervention group received nearly 100% of the total volume during the fi rst quarter of surgery. The intervention group had signifi cantly fewer postoperative complications than the control group as well as a 2-day reduction in average length of stay. Circulating levels of interleukin-6 and cytokines also were signifi cantly lower in the intervention group, which suggests that the intervention blunted the infl ammatory response to surgery.
Fluid management must be individualized
Intraoperative fl uid needs are highly variable and patient-specifi c. Parker et al tested an approach in which they universally administered 500 mL of a gelatin colloid solution prior to hip fracture surgery and compared it with a conventional intravenous saline crystalloid solution; neither approach used invasive intraoperative monitoring. 11 They found no signifi cant difference in length of stay, 30-day mortality, or postoperative complications between the two study arms. They concluded that more invasive investigation of patients before or during surgery may have been able to identify a subgroup in whom the colloid therapy or more precise fl uid control would have been benefi cial.
  THE ROAD AHEAD
Fluid management remains suboptimal
Despite being a fundamental component of surgical and perioperative care, fl uid management remains suboptimal in clinical practice. I can speak most directly to the practice of fl uid management in the United Kingdom (UK), but the same types of shortcomings apply broadly to the United States as well.
In 1999, the UK's National Confi dential Enquiry into Patient Outcome and Death examined perioperative death in the UK, concluding that patients were dying as a result of too much or too little perioperative fl uid administration. 12 Their report cited staff inexperience as an important contributor to the problem, as junior physicians order and deliver the majority of postoperative fl uid regimens.
This cautionary report from 10 years ago appears not to have produced substantial improvements in practice, at least according to a recent study by Walsh et al. 13 These researchers prospectively audited postoperative fl uid management practices in 106 consecutive patients undergoing laparotomy in a UK general surgical unit over a 6-month period in 2003. They found no correlation between available fl uid balance data and the quantities of fl uids prescribed, suggesting that physicians routinely ignore such data when prescribing. Fifty-four percent of the patients developed at least one fl uid-related complication. Patients routinely received signifi cantly greater amounts of fl uid and
